Comparison between next-generation sequencing and multiplex polymerase chain reaction assays for nonsmall-cell lung cancer molecular diagnosis.

MLA

Murakami, Shuji, et al. “Comparison between Next-Generation Sequencing and Multiplex Polymerase Chain Reaction Assays for Nonsmall-Cell Lung Cancer Molecular Diagnosis.” Cancer Medicine, vol. 13, no. 7, Apr. 2024, p. e7162. EBSCOhost, https://doi.org/10.1002/cam4.7162.

APA

Murakami, S., Shinada, K., Otsutsumi, Y., Komine, F., Yuan, Y., Nakamura, J., Katakura, S., Kondo, T., Kato, T., Yokose, T., & Saito, H. (2024). Comparison between next-generation sequencing and multiplex polymerase chain reaction assays for nonsmall-cell lung cancer molecular diagnosis. Cancer Medicine, 13(7), e7162. https://doi.org/10.1002/cam4.7162

Chicago

Murakami, Shuji, Kanako Shinada, Yuka Otsutsumi, Fumiko Komine, Yuan Yuan, Junko Nakamura, Seigo Katakura, et al. 2024. “Comparison between Next-Generation Sequencing and Multiplex Polymerase Chain Reaction Assays for Nonsmall-Cell Lung Cancer Molecular Diagnosis.” Cancer Medicine 13 (7): e7162. doi:10.1002/cam4.7162.